ARRB1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, Li et al. show that ARRB1 expression promotes progression of CML and its expression levels increase as CML progresses from an early chronic phase (CP) through an accelerated phase (AP) to a blast crisis phase (BC).